Could the gut microbiome hold the key to fighting cancer?

BioPharma Dive December 16, 2024

Sponsored content By MaaT Pharma

Trillions of bacteria, fungi and viruses live within our bodies, making up our microbiome. Scientists have been studying the role these microorganisms play in our health, and in recent years, the focus has shifted to oncology. Specifically, could mitigate complications of cancer treatments and potentially improve the body’s response to certain cancer treatments leading to improved survival?

MaaT Pharma is at the forefront of innovation in this field, striving to achieve the first-ever approval of a microbiome-driven immunomodulator in oncology.

In 2022, the biotech company launched a Phase 3 clinical trial, in Europe, in patients with acute graft versus host disease (aGvHD), and topline results are anticipated as early as January 2025. If approved, the...

Today's Sponsors

Today's Sponsor